Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate LifeMD, Inc. before investing.
In this article, we go over a few key elements for understanding LifeMD, Inc.’s stock price such as:
- LifeMD, Inc.’s current stock price and volume
- Why LifeMD, Inc.’s stock price changed recently
- Upgrades and downgrades for LFMD from analysts
- LFMD’s stock price momentum as measured by its relative strength
About LifeMD, Inc. (LFMD)
Before we jump into LifeMD, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology. It also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. Further, it offers GLP-1 for weight management and in-home health monitoring devices. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.
Want to learn more about LifeMD, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about LifeMD, Inc..
LifeMD, Inc.’s Stock Price as of Market Close
As of December 02, 2025, 4:00 PM, CST, LifeMD, Inc.’s stock price was $3.560.
LifeMD, Inc. is down 0.28% from its previous closing price of $3.570.
During the last market session, LifeMD, Inc.’s stock traded between $3.460 and $3.620. Currently, there are approximately 46.16 million shares outstanding for LifeMD, Inc..
LifeMD, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.
LifeMD, Inc. Stock Price History
LifeMD, Inc.’s (LFMD) price is currently down 7.05% so far this month.
During the month of December, LifeMD, Inc.’s stock price has reached a high of $3.730 and a low of $3.460.
Over the last year, LifeMD, Inc. has hit prices as high as $15.840 and as low as $3.430. Year to date, LifeMD, Inc.’s stock is down 28.08%.
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
What Caused LifeMD, Inc. Stock’s Price to Dip?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of December 01, 2025, there were 0 analysts who downgraded LifeMD, Inc.’s stock and 1 analyst who upgraded over the last month.
Additionally, you'll want to evaluate LifeMD, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on LifeMD, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
LifeMD, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about LifeMD, Inc. (LFMD) by visiting AAII Stock Evaluator.
Relative Price Strength of LifeMD, Inc.
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of December 01, 2025, LifeMD, Inc. has a weighted four-quarter relative price strength of 1.03%, which translates to a Momentum Score of 63 and is considered to be Strong.
Want to learn more about how LifeMD, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
LifeMD, Inc. Stock Price: Bottom Line
As of December 2, 2025, LifeMD, Inc.’s stock price is $3.560, which is down 0.28% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like LifeMD, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
at only 23.3%
Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.